Skip to content
10-K

Annual Report

enVVeno Medical Corp NVNO

0001493152-26-012928

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 24, 2026 655.52K sh
Shares Diluted FY 2025 · Dec 31, 2025 589K sh
Capex FY 2025 · Dec 31, 2025 $5K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$15.57M
Short Term Investments FY 2025 · Dec 31, 2025 $25.15M
Cash And Equivalents FY 2025 · Dec 31, 2025 $3.07M
Stockholders Equity FY 2025 · Dec 31, 2025 $27.13M
Current Liabilities FY 2025 · Dec 31, 2025 $2.12M
Total Liabilities FY 2025 · Dec 31, 2025 $2.43M
Current Assets FY 2025 · Dec 31, 2025 $28.83M
Total Assets FY 2025 · Dec 31, 2025 $29.56M
Eps Diluted FY 2025 · Dec 31, 2025 −$33.06
Eps Basic FY 2025 · Dec 31, 2025 −$33.06
Sga Expense FY 2025 · Dec 31, 2025 $10.92M
Rd Expense FY 2025 · Dec 31, 2025 $9.98M
Net Income FY 2025 · Dec 31, 2025 −$19.47M
Operating Income FY 2025 · Dec 31, 2025 −$20.9M